Nowak, D., Demmerle, M., Klär, A., Streuer, A., Riabov, V., Altrock, E., . . . Schmitt, N. (2025). Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243: Research letter. British journal of haematology, 207(6), . https://doi.org/10.1111/bjh.70203
Chicago-Zitierstil (17. Ausg.)Nowak, Daniel, et al. "Primary CD34+ Cells of Patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome Are Highly Sensitive to Targeted Treatment with TAK-243: Research Letter." British Journal of Haematology 207, no. 6 (2025). https://doi.org/10.1111/bjh.70203.
MLA-Zitierstil (9. Ausg.)Nowak, Daniel, et al. "Primary CD34+ Cells of Patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome Are Highly Sensitive to Targeted Treatment with TAK-243: Research Letter." British Journal of Haematology, vol. 207, no. 6, 2025, https://doi.org/10.1111/bjh.70203.